There is additional evidence to suggest that AURKA can also inhibit p53 via the AKT/MDM2 axis in gastric cancer cells, however this remains to be shown in neuroblastoma (Dar et al., 2008). This evidence concerns the gene MDM2 and neuroblastoma.